WEST LAFAYETTE, Ind., March 4, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases, announced today that the company will host a conference call for investors and analysts on Thursday, March 10, 2011 at 4:30 PM Eastern Standard Time to discuss its financial results.
